Free Trial

Smith & Nephew (SNN) Competitors

$28.40
+0.10 (+0.35%)
(As of 07/12/2024 08:52 PM ET)

SNN vs. ZBH, STE, ALGN, MSA, ENOV, CDRE, ESTA, AVNS, ZJYL, and SMTI

Should you be buying Smith & Nephew stock or one of its competitors? The main competitors of Smith & Nephew include Zimmer Biomet (ZBH), STERIS (STE), Align Technology (ALGN), MSA Safety (MSA), Enovis (ENOV), Cadre (CDRE), Establishment Labs (ESTA), Avanos Medical (AVNS), Jin Medical International (ZJYL), and Sanara MedTech (SMTI). These companies are all part of the "surgical appliances & supplies" industry.

Smith & Nephew vs.

Zimmer Biomet (NYSE:ZBH) and Smith & Nephew (NYSE:SNN) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, community ranking, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

Zimmer Biomet pays an annual dividend of $0.96 per share and has a dividend yield of 0.9%. Smith & Nephew pays an annual dividend of $0.90 per share and has a dividend yield of 3.2%. Zimmer Biomet pays out 20.8% of its earnings in the form of a dividend.

Zimmer Biomet has higher revenue and earnings than Smith & Nephew.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zimmer Biomet$7.39B3.02$1.02B$4.6223.53
Smith & Nephew$5.55B2.24$263MN/AN/A

Zimmer Biomet has a net margin of 12.93% compared to Zimmer Biomet's net margin of 0.00%. Smith & Nephew's return on equity of 12.70% beat Zimmer Biomet's return on equity.

Company Net Margins Return on Equity Return on Assets
Zimmer Biomet12.93% 12.70% 7.43%
Smith & Nephew N/A N/A N/A

Zimmer Biomet presently has a consensus price target of $130.59, indicating a potential upside of 20.15%. Given Smith & Nephew's higher possible upside, equities analysts plainly believe Zimmer Biomet is more favorable than Smith & Nephew.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zimmer Biomet
1 Sell rating(s)
10 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.29
Smith & Nephew
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60

Zimmer Biomet has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500. Comparatively, Smith & Nephew has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500.

88.9% of Zimmer Biomet shares are owned by institutional investors. Comparatively, 25.6% of Smith & Nephew shares are owned by institutional investors. 1.0% of Zimmer Biomet shares are owned by company insiders. Comparatively, 1.0% of Smith & Nephew shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Zimmer Biomet had 5 more articles in the media than Smith & Nephew. MarketBeat recorded 7 mentions for Zimmer Biomet and 2 mentions for Smith & Nephew. Smith & Nephew's average media sentiment score of 0.59 beat Zimmer Biomet's score of 0.33 indicating that Zimmer Biomet is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Zimmer Biomet
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Smith & Nephew
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Zimmer Biomet received 445 more outperform votes than Smith & Nephew when rated by MarketBeat users. Likewise, 67.94% of users gave Zimmer Biomet an outperform vote while only 54.40% of users gave Smith & Nephew an outperform vote.

CompanyUnderperformOutperform
Zimmer BiometOutperform Votes
890
67.94%
Underperform Votes
420
32.06%
Smith & NephewOutperform Votes
445
54.40%
Underperform Votes
373
45.60%

Summary

Zimmer Biomet beats Smith & Nephew on 14 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNN vs. The Competition

MetricSmith & NephewSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$12.42B$8.93B$5.17B$18.20B
Dividend Yield3.18%1.18%5.25%3.49%
P/E RatioN/A11.5296.4920.79
Price / Sales2.2448.162,139.0115.25
Price / Cash8.8421.1931.9016.25
Price / Book2.385.784.904.83
Net Income$263M$172.21M$105.38M$967.95M
7 Day Performance4.57%3.44%124.12%5.63%
1 Month Performance12.21%2.26%127.80%6.99%
1 Year Performance-8.42%-15.82%132.23%10.31%

Smith & Nephew Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZBH
Zimmer Biomet
4.572 of 5 stars
4.57 / 5 stars
$108.69
+0.5%
$130.59
+20.1%
-23.7%$22.36B$7.39B23.5318,000
STE
STERIS
4.2291 of 5 stars
4.23 / 5 stars
$221.72
+1.8%
$241.60
+9.0%
-3.2%$21.92B$5.14B58.0418,179Positive News
ALGN
Align Technology
4.8724 of 5 stars
4.87 / 5 stars
$242.65
-5.3%
$346.50
+42.8%
-33.9%$18.27B$3.86B39.9821,610Analyst Revision
Positive News
MSA
MSA Safety
3.7206 of 5 stars
3.72 / 5 stars
$193.06
+0.7%
$189.50
-1.8%
+16.0%$7.60B$1.79B28.605,100Short Interest ↑
ENOV
Enovis
2.5655 of 5 stars
2.57 / 5 stars
$46.03
+0.8%
$71.44
+55.2%
-29.4%$2.52B$1.71B-30.696,550
CDRE
Cadre
2.6454 of 5 stars
2.65 / 5 stars
$36.81
+4.0%
$41.25
+12.1%
+65.7%$1.49B$482.53M36.452,435Short Interest ↑
Negative News
ESTA
Establishment Labs
1.1009 of 5 stars
1.10 / 5 stars
$44.89
-1.6%
$54.00
+20.3%
-36.2%$1.24B$165.15M-14.30908
AVNS
Avanos Medical
2.5664 of 5 stars
2.57 / 5 stars
$21.08
-0.5%
N/A-16.3%$967.66M$673.30M-15.853,771Short Interest ↓
News Coverage
Positive News
ZJYL
Jin Medical International
0 of 5 stars
0.00 / 5 stars
$2.84
+1.1%
N/A-73.1%$440.20MN/A0.00245Positive News
SMTI
Sanara MedTech
1.8022 of 5 stars
1.80 / 5 stars
$28.88
+0.3%
$44.00
+52.4%
-27.8%$249.10M$64.99M-48.95107Positive News

Related Companies and Tools

This page (NYSE:SNN) was last updated on 7/15/2024 by MarketBeat.com Staff

From Our Partners